GW Pharmaceutical, Village Farms, And Tilray Among Canadian Cannabis Stock Showing Strong Growth Potential

Canadian Cannabis stocks have been hot in recent weeks as most benefitted from the demand in cannabis products during the lockdown. Although in the past year most cannabis stocks were facing financial issues some have implemented turnaround strategies and are surprisingly performing well.

GW Pharmaceuticals waiting for approval of Epidiolex in Epilepsy

One of the promising Candian cannabis stocks currently is GW Pharmaceuticals Plc (NASDAQ:GWPH). The biopharmaceutical company has a promising cannabinoid-based drug called Epidiolex which once approved will treat epilepsy.

The company has a PDUFA action data and expects the FDA to issue its decision on its NDA application for treatment of seizures this week. The company plans to release its Q2 2020 financial results as well as operation progress on August 6, 2020. Currently GW Pharmaceutical has other products lined up which is an indication of the massive potential the stock holds.

Village Farms among cost-effective Canadian Cannabis stocks

Another pot stock poised for more growth is Village Farms International (NASDAQ:VFF). Village Farms is among the most cost-efficient growers in the industry today thanks to its Pure Sunfarms subsidiary’s efficient growing operations.

In the first quarter, the company’s total cultivation costs per gram were $0.64 which is a massive YOY improvement from $1.04. By industry standards, this is very cheap and thus makes the company competitive with other large operators. The company is among the few cannabis operators that have been profitable and in Q1 its net income was $4.2 million which was the fifth successful profitable quarter the company recorded.

Tilray reported 126% YoY growth in sales in Q1

Tilray (NASDAQ:TRLY) is another stock that although struggling with losses holds huge potential in the industry. In Q1 the company reported 126% YoY growth in sales to $52.1 million thanks to its diversified operations.

Revenue from cannabis operation was around 59% of total sales at around $30.8 million in the quarter with hemp sales making up 41% of the sales. The company closed a CA$419 million acquisition deal of hemp foods company Manitoba Harvest.

This article by Money News National is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Money News National has no position in the stocks mentioned. Thank you for reading.

__________________

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

LEAVE A REPLY

Please enter your comment!
Please enter your name here